What is this medicine used for?
FDA-approved uses
- Opioid use disorder: medically supervised withdrawal and maintenance — Adults in an appropriate treatment setting. Current program requirements and individualized monitoring apply; no analgesic conversion inferred.Methadone 40 mg dispersible tablets for oral suspension; Methadose 10 mg/mL oral concentrate.
What should I expect?
Treatment aims to control withdrawal and craving across the day. Early dosing requires close assessment because methadone builds up and breathing effects can outlast the effect a person notices.
Report persistent cravings, withdrawal or sleepiness to the treatment program. Taking extra medicine to obtain quicker relief can be dangerous.
How do I take it safely?
For opioid use disorder, follow the authorized treatment program’s dosing and take-home plan. Oral concentrates and dispersible tablets require their own measuring or preparation instructions; they are not for injection. Check the exact concentration and use the supplied measuring device.
Methadone can accumulate during starting treatment, dose changes or interactions. Do not take extra doses for breakthrough withdrawal. After missed doses, contact the program before resuming: the prior dose may no longer be safe. Never double.
Alcohol, benzodiazepines and other sedatives can dangerously suppress breathing. Review all prescriptions and supplements, including medicines affecting heart rhythm, serotonin or liver enzymes. Treatment teams should coordinate risk management rather than abruptly withdrawing care.
Keep an overdose-reversal medicine available and teach close contacts to respond. Monitor sedation, breathing, blood pressure, interactions and, when indicated, heart rhythm and electrolytes. Store take-home doses securely; accidental exposure can kill a child.
Discuss pregnancy and breastfeeding with the program; newborn withdrawal is possible and requires planning. Do not abruptly stop maintenance treatment. Any taper needs an individualized plan, relapse support and continued overdose-rescue access.
Do not use with significant breathing suppression, severe asthma without appropriate monitoring and resuscitation facilities, or known or suspected bowel obstruction. Liver or kidney impairment needs additional assessment.
Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.
What side effects should I know about?
- Constipation, nausea, sweating, sleepiness, dizziness and low blood pressure.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)METHADOSE DISPERSIBLE- methadone hydrochloride tablet
- View FDA Prescribing Information (PDF) (opens in a new tab)METHADOSE- methadone hydrochloride concentrate
Which warning signs need help?
- Very slow or absent breathing, inability to wake, blue or gray lips, collapse or suspected overdose is an emergency. Call emergency services and give available opioid overdose-reversal medicine as instructed; repeat doses may be needed. Stay with the person and follow emergency breathing or CPR instructions.
- Boxed risks include fatal breathing suppression, dangerous heart-rhythm changes, accidental ingestion, abuse and major drug interactions, alongside restrictions on opioid-use treatment. Breathing suppression can occur at prescribed doses, especially when starting or changing treatment.
- Fainting or palpitations needs urgent assessment. Fever with agitation, diarrhea or rigid muscles can be serotonin syndromeSerotonin syndromeSerotonin syndrome (also called serotonin toxicity) is a potentially life-threatening drug reaction caused by excessive serotonin activity in the nervous system.It can develop soon after starting or increasing a serotonin-affecting medicine, or combining it with another medicine or substance that affects serotonin.Possible signs include agitation or confusion, sweating, fever, diarrhea, shaking, and stiff or twitching muscles.Seek urgent medical help if you suspect serotonin syndrome. Severe symptoms, such as a high fever, seizures, or loss of consciousness, need emergency care.. Report excessive sedation, severe dizziness or unexplained marked weakness promptly; adrenal-hormone deficiency and severe low blood pressure are additional concerns.
What else should I know to stay safe?
- Follow the authorized opioid-treatment program. Concentrates and dispersible tablets need exact product-specific preparation and are not for injection. Methadone accumulates; do not take extra doses for withdrawal, and contact the program before restarting after missed treatment because the previous dose may no longer be safe.
- Do not use with significant breathing suppression, severe asthma without appropriate monitoring and rescue facilities, known or suspected bowel obstruction, or product allergy. Review liver and kidney health, sedatives and medicines affecting heart rhythm, serotonin or methadone breakdown.
- Keep overdose-reversal medicine accessible and take-home doses secure from children. Monitor breathing, sedation, blood pressure and heart rhythm or electrolytes when indicated. Discuss pregnancy and breastfeeding; newborn withdrawal needs planning. Do not abruptly stop maintenance treatment: withdrawal, return to opioid use and loss of tolerance increase danger.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- Feeling withdrawal before the next visit is a reason to contact the program, not to take a catch-up dose. Accumulation makes unsupervised changes hazardous.
- Missing treatment can change tolerance. The previous dose may no longer be safe after an interruption.
How does it work?
Methadone activates opioid receptors, receiving sites used by medicines and drugs such as morphine and heroin. This can suppress craving and withdrawal, the physical and emotional symptoms that follow a reduction in opioid effects after the body has adapted to them. Methadone can also slow breathing, so beneficial and harmful effects can occur together.
How was this medicine developed?
Methadone’s US labeling identifies initial approval in 1947. The reviewed Methadose oral-concentrate application was approved in 1973; its role in long-term opioid treatment developed alongside structured monitoring and support.
How do I say the name?
Methadone: METH-a-done. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
40 mg tablets for oral suspension
Disperse before swallowing; 10 mg increments may not fit induction or taper needs.
10 mg/mL oral concentrate
Measure and dilute accurately; do not confuse mg with mL.
Other analgesic formulations
Separate pain products and conversion instructions are outside this article’s dose scope.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Methadone: current prescribing information — mechanism explanation
Scope: Mechanism explanation only. Source sections checked: 12.1 Mechanism of Action; 12.2 Pharmacodynamics; 12.3 Pharmacokinetics; 9.3 Dependence; 5.1 Life-Threatening Respiratory Depression..
- Methadone: FDA approval history
- Methadone: patient medicine information
- Methadose current oral-concentrate prescribing information
- Methadose FDA prescribing information
- Methadone: Package Insert / Prescribing Information / MOA
- Buprenorphine/naloxone: prescribing information
- SAMHSA current opioid-treatment-program rules and FAQs
- Methadone: verified neutral parent, PubChem CID 4095
- ISMP List of Confused Drug Names
- ISMP List of High-Alert Medications in Acute Care Settings
- ISMP List of High-Alert Medications in Community/Ambulatory Care Settings
- High-Alert Medications in Long-Term Care (LTC) Settings
- Serotonin syndrome: MedlinePlus Medical Encyclopedia
- Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
Giving medicine safely to children: family guide (PDF, 3 pages)

